A detailed history of Davidson Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Davidson Trust CO holds 1,928 shares of AMGN stock, worth $599,376. This represents 0.32% of its overall portfolio holdings.

Number of Shares
1,928
Previous 1,928 -0.0%
Holding current value
$599,376
Previous $555,000 1.26%
% of portfolio
0.32%
Previous 0.36%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$255.7 - $288.46 $49,861 - $56,249
195 Added 11.25%
1,928 $555,000
Q3 2023

Nov 08, 2023

BUY
$218.65 - $271.46 $15,742 - $19,545
72 Added 4.33%
1,733 $465,000
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $20,784 - $24,576
-97 Reduced 5.52%
1,661 $368,000
Q1 2023

Apr 24, 2023

BUY
$225.79 - $275.2 $107,250 - $130,720
475 Added 37.02%
1,758 $424,000
Q2 2022

Jul 27, 2022

SELL
$230.71 - $256.74 $30,915 - $34,403
-134 Reduced 9.46%
1,283 $312,000
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $28,943 - $32,019
-132 Reduced 8.52%
1,417 $343,000
Q4 2021

Jan 28, 2022

SELL
$198.88 - $227.6 $15,313 - $17,525
-77 Reduced 4.74%
1,549 $348,000
Q3 2021

Nov 03, 2021

BUY
$212.27 - $248.7 $4,669 - $5,471
22 Added 1.37%
1,626 $345,000
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $3,970 - $4,405
17 Added 1.07%
1,604 $391,000
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $30,845 - $35,945
-139 Reduced 8.05%
1,587 $394,000
Q4 2020

Feb 10, 2021

SELL
$216.38 - $257.67 $14,281 - $17,006
-66 Reduced 3.68%
1,726 $396,000
Q3 2020

Nov 02, 2020

BUY
$234.65 - $260.95 $56,316 - $62,628
240 Added 15.46%
1,792 $454,000
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $8,110 - $9,952
41 Added 2.71%
1,552 $365,000
Q1 2020

May 06, 2020

BUY
$182.24 - $241.7 $32,620 - $43,264
179 Added 13.44%
1,511 $305,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $252,027 - $323,942
1,332 New
1,332 $320,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Davidson Trust CO Portfolio

Follow Davidson Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Trust CO with notifications on news.